A site where you can find recommended contractors for non-clinical testing|effical " Non-Clinical CROs and Agencies " Shokukanken Inc.

Shokukanken Inc.

Table of Contents
Table of Contents

Shokukanken, Inc. (hereinafter referred to as “Shokukanken”) is among the few CROs in Japan specializing in veterinary drugs and conducts a large volume of contracted studies. This overview presents the features of its nonclinical studies, an example disease model, and representative case studies. It is intended as a reference when selecting a CRO for nonclinical studies.

Non-Clinical Studies at Shokukanken

High-quality safety, pharmacology, and pharmacokinetic studies

Shokukanken provides high-quality safety studies, drug efficacy/pharmacology studies, and pharmacokinetic studies in accordance with applicable guidelines. In the veterinary field, the organization conducts contracted studies as a contract research organization (CRO).

To apply for registration of veterinary drugs with Japan’s regulatory authorities, both clinical and nonclinical studies are required to address efficacy, safety, and quality control. Shokukanken supports new-drug development for food-producing animals and companion animals in accordance with GCP and GLP regulations.

In-house Non-Clinical testing and clinical collaborations

Shokukanken conducts nonclinical testing in in-house breeding facilities and performs clinical trials in collaboration with livestock farms. The organization also maintains a robust testing and analytical framework. Available analytical instruments include LC/MS, LC/MS/MS, GC/MS/MS, TOF-MS, and dissolution testers.

Shokukanken conducts programs spanning nonclinical studies, clinical studies, and postmarketing use-results surveys for veterinary drugs. In addition, the organization undertakes veterinary pharmaceutical affairs and consulting services related to marketing authorization and re-examination.

Partner Companies associated with Shokukanken

Fuji Micra Co., Ltd.

Fuji Micra has independently developed ultra-small experimental pigs that weigh under 10 kg and measure less than 80 cm in length at six months of age—small enough to be housed in standard dog cages. Other disease models including atherosclerosis and chronic renal failure Micro Minipigs are available.

Hoku-shin Clinical Co.

Hoku-shin Clinical provides comprehensive contracted clinical laboratory services and consultation related to clinical testing and laboratory equipment, primarily in Nagano Prefecture. As a partner to regional medical institutions, the company supplies reliable clinical laboratory data through outsourced testing services.

Non-Clinical Case Studies — Shokukanken

Quality control testing

Testing is performed based on Attachment 2, “Guidelines for Application Materials for Approval of Veterinary Drugs,” within “Handling of Administrative Affairs Related to the Act on Quality, Efficacy and Safety Assurance of Drugs and Medical Devices.” Conducted test examples stipulated in the Standards for Biological Products for Veterinary Use include safety tests, potency tests, toxicity limit confirmation tests, adventitious virus–negative tests, sterility tests, characteristics tests, pH tests, and moisture-content tests.

Reference source: Official website of the Institute of Food Environment and Hygienehttps://www.shokukanken.com/service/quality-control/

Various toxicity tests

Development studies are conducted under appropriate information storage and management in accordance with GLP and ISO. Available services include toxicity tests and skin irritation tests. Supported species include medaka (for fish) and, among rodents, mice, rats, hamsters, guinea pigs, and rabbits.

Reference source: Official website of the Institute of Food Environment and Hygienehttps://www.shokukanken.com/kensa_cat/consignment-test/general/various-toxicity/

Laboratory of food environment and hygiene (Shokukanken) Company Information

The company's strength lies in its proposals to create "one" from "zero" in business domains ranging from "farms" to "dining tables.

Address 561-21 Araguchi-cho, Maebashi, Gunma prefecture, Japan
Tel 027-230-3411
Website https://www.shokukanken.com/
3 Recommended Contract Research Organizations for Non-Clinical Studies
— by Target goal and Expertise

In drug discovery, the quality and efficiency of non-clinical studies have a direct impact on clinical success rates, development costs, and overall length of time required in R&D. In recent years, there has been more demand for clinically relevant data, globally accepted reliability, and accurate early-stage screening. Thus, it is more important than ever to select the right CRO (Contract Research Organization) for strategic approach.
In this article, we highlight three CROs with proven technical capabilities, expertise, and long standing track records. These are our TOP 3 choices based on their capabilities and the specific target goals of the researchers for their non-clinical studies.

Pharmacology (Efficacy) Studies
Replicate unknown pathological models and
Discovery to clinically oriented drug evaluation
SMC Laboratories, Inc.
SMC Laboratories, Inc.
Reference: SMC Laboratories, Inc. official website (https://www.smccro-lab.com/jp/)
  • SMC Laboratories, Inc. has established a disease models using patented mouse technologies. The company has established proprietary pathological models—particularly in liver disease and fibrosis—and continues to expand their approach across a wide range of models in cancer, inflammation, and metabolic diseases.
  • From exploratory research to clinically oriented efficacy evaluation, SMC offers customized study designs, dosing strategies, and evaluation analysis tailored to each project. Their collaborative approachallows researchers to discuss and refine study plans together with SMC’s expert scientists.

  • With flexible small-scale study options and strong technical support, SMC Laboratories, Inc. is an ideal partner for start-ups, biotech ventures, and academic institutions alike.
Safety Studies
Comprehensive Safety Evaluation for FIH Applications
Labcorp Holdings Inc.
(Labcorp Drug Development)
Labcorp Holdings Inc.
Reference: Labcorp Holdings Inc. official website (https://jp.labcorp.com/)
  • Labcorp Holdings Inc. provides a fully integrated GLP testing system aligned with international regulatory standards, including FDA, EMA, and PMDA requirements. All studies are conducted under ICH-compliant quality assurance, making it ready for data submission.
  • The company has extensive expertise in long-term toxicity studies such as Segment I–III reproductive and carcinogenicity studies, as well as 2-year chronic toxicity assessments.
  • Labcorp Holdings Inc.’s comprehensive approach enables sponsors to efficiently outsource the entire preclinical package from toxicology, toxicokinetic (TK), and safety pharmacology study design to execution. This accelerates a path to First-in-Human (FIH) trials. For most of the global drug developers, this all-in-one service structure minimizes cost, risk, and expedite the time before advancing to clinical phase.
Pharmacokinetic (PK/PD) Studies
High-Precision Bioanalysis for Clinically Predictive PK/PD Evaluation
PhoenixBio Co., Ltd.
PhoenixBio Co., Ltd.
Source: PhoenixBio Co., Ltd. Official Website (https://phoenixbio.co.jp/)
  • PhoenixBio Co., Ltd.offers pharmacokinetic and hepatic metabolism studies using their proprietary PXB-mouse®, a humanized-liver chimeric mouse model. This platform enables the acquisition of data with high clinical correlation in ADME, drug–to-drug interaction studies, bridging the gap between preclinical and clinical stages.
  • With advanced LC-MS/MS-based bioanalysis, PhoenixBio Co., Ltd. provides aseamless workflow from plasma concentration measurement and metabolite identification to quantitative validation.

  • The company offersan integrated evaluation analysiscovering pharmacokinetics, hepatotoxicity, and safety with flexibility to accommodate complex modalities such as oligonucleotide and middle-molecule therapeutics. For compounds where hepatic metabolism is a development bottleneck—or where quantitative, reproducible exposure data are critical—PhoenixBio Co., Ltd. delivers unmatched analytical precision and consistency.

By region
list of animal models
Expertise & Track Record
3 Recommended Contract Non-Clinical Testing Services